Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • School of Medicine (MU)
    • Department of Family and Community Medicine (MU)
    • Family Physicians Inquiries Network (MU)
    • Priority Updates from the Research Literature Surveillance (PURLS) (MU)
    • Priority Updates to Research Literature (PURLs)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • School of Medicine (MU)
    • Department of Family and Community Medicine (MU)
    • Family Physicians Inquiries Network (MU)
    • Priority Updates from the Research Literature Surveillance (PURLS) (MU)
    • Priority Updates to Research Literature (PURLs)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleSubjectIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleSubjectIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Go low or say No to aggressive systolic BP goals?

    Day, Margaret
    Steverner, James J.
    View/Open
    [PDF] AggressiveSystolicBPGoals.pdf (96.06Kb)
    Date
    2016
    Format
    Article
    Metadata
    [+] Show full item record
    Abstract
    "Go low" or say "No" to aggressive systolic BP goals? The SPRINT trial demonstrated the benefits -- and risks -- of reaching a systolic target <120 mm Hg in non-diabetic patients at high risk for CV events. Here's who might benefit. Practice changer: Consider treating non-diabetic patients age greater than or equal to 50 years to a systolic blood pressure (SBP) target <120 mm Hg as compared to <140 mm Hg when the benefits -- lower rates of fatal and nonfatal cardiovascular (CV) events and death from any cause -- are likely to outweigh the risks from possible additional medication.
    URI
    https://hdl.handle.net/10355/49260
    Part of
    Journal of family practice, 65, no. 05 (May 2016): 342-344.
    Rights
    OpenAccess.
    This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
    Collections
    • Priority Updates to Research Literature (PURLs)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems